| Tammy Sue Wright, | |
|
20 S Sprigg St, Cape Girardeau, MO 63703-6212 | |
| (573) 651-4177 | |
| Not Available |
| Full Name | Tammy Sue Wright |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 20 S Sprigg St, Cape Girardeau, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780367342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 2010042364 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tammy Sue Wright, 20 S Sprigg St, Cape Girardeau, MO 63703-6212 Ph: (573) 651-4177 | Tammy Sue Wright, 20 S Sprigg St, Cape Girardeau, MO 63703-6212 Ph: (573) 651-4177 |
News Archive
The Scripps Research Institute (TSRI) today announced the formation of Scripps Advance, a new drug discovery initiative to translate early-stage biomedical research projects, both internal and external to TSRI, into clinical development candidates.
Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
UT Southwestern researchers attempting to transform supporting brain cells into neurons instead reprogrammed mature inhibitory neurons into a different type of neuron that creates the neurotransmitter lost in Parkinson's disease.
› Verified 9 days ago
Melissa Kelley, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5480 | |
Sheila Ann Brown, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 20 S Sprigg St, Cape Girardeau, MO 63703 Phone: 573-651-4177 | |
Melissa Arlane Landreth, RNC, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5565 | |
Mrs. Laura Ziegler Standridge, MSN, APRN, FNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 28 S Mount Auburn Rd, Cape Girardeau, MO 63703 Phone: 573-331-3350 Fax: 573-331-3351 | |
Pam J Hiett, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 304 S Mount Auburn Rd, Cape Girardeau, MO 63703 Phone: 573-651-1687 Fax: 573-651-8734 | |
Ashley Lipke, RN, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 408 S Broadview St, Cape Girardeau, MO 63703 Phone: 573-332-0808 Fax: 573-339-7945 | |
Kelsey Lyn Tillman, DNP, APRN, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3203 Blattner Drive, Cape Girardeau, MO 63703 Phone: 573-803-1884 Fax: 573-768-8429 |